UNITED STATES
                                    SECURITIES AND EXCHANGE COMMISSION
                                              Washington, D.C. 20549

                                                         FORM 10-K
[X]Annual Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934

For the Fiscal Year Ended December 31, 1995  


Commission file number      2-67099    

                   MOMED Holding Co.                              
 (Exact name of registrant as specified in its charter)

      MISSOURI                                         43-1473496 
(State or other jurisdiction of    (IRS Employer Identification #)
incorporation or organization)

 8630 Delmar Blvd., Suite 100, St. Louis, MO              63124  
(Address of principal executive offices)                        
Registrant's telephone number, including area code:314-872-8000   

Securities registered pursuant to Section 12(b) of the Act:

Title of each class      Name of each exchange on which registered

Securities registered pursuant to Section 12(g) of the Act:
                    
                Class A Common Stock, $1.00 par value             
                          (Title of class)

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities and Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.  Yes  X         No      .

Indicated by check mark if disclosure of delinquent filers pursuant
to Item 405 of Regulation S-K (229.405 of this chapter) is not
contained herein, and will not be contained, to the best of
registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K [ ] (Amended by Exch Act Rel No.
28869, eff. 5/1/91.)
                     
The aggregate market value of Class A shares held by nonaffilities
as of March 1, 1996 was $1,680,135.

The number of Class A shares outstanding as of March 1, 1996 was
739,584.

The following documents are incorporated herein by reference:
Annual Report to Stockholders for the Year Ended December 31, 1995 
                     Part II, IV    


                                   Part I
Item 1. Business

    A.       General Development of Business
             On May 12, 1988, the shareholders of Missouri Medical
             Insurance Company "MOMEDICO" approved a plan to exchange the
             issued and outstanding shares of the Company for shares of
             MOMED Holding Co.  During 1989, the exchange of Class A and
             Class B common shares of MOMED Holding Co. for the Class A
             and Class B common shares of MOMEDICO was completed, and
             222,343 Class A and 24,185 Class B common shares were issued. 
             On September 9, 1989, MOMEDICO at a special meeting of the
             shareholders approved a change in the par value of its Class
             A common stock from $1.00 per share to $3,000 per share and
             fractional shares were redeemed for cash.  As a result of the
             action by MOMEDICO shareholders, MOMED Holding Co. owns 100%
             of the Class A and Class B common shares of MOMEDICO.

             On August 16, 1994, the shareholders approved the exchange of
             Class B common shares for Class A common shares on a share-
             for-share basis.  Also, in connection with the share exchange
             agreement, 24,185 shares of Class C non-voting common stock
             was authorized and issued to the Missouri State Medical
             Association (MSMA).  MSMA has an option to sell the Class C
             shares and the Company is required to purchase such shares at
             a per share consideration of $24.81 with the aggregate cash
             consideration not to exceed $600,000.  As of March 24, 1996,
             no shares have been redeemed by the Company.

             Also, effective January 1, 1989, MOMED Holding Co. acquired
             by purchase 100% of the outstanding shares of Professional
             Liability Associates, Inc.  Professional Liability
             Associates, Inc. is actively trying to market claims
             management services to hospitals and other self insured
             groups.  During 1990, MOMED Holding Co. acquired 100% of the
             issued and outstanding shares of Momedico Professional
             Services, Inc. from MOMEDICO.  Momedico Professional
             Services, Inc. holds a brokers license and is investigating
             other types of insurance that could be provided to physicians
             and dentists through an agency arrangement.  Since 1984,
             Momedico Professional Services, Inc. has purchased furniture
             and equipment which is leased to MOMEDICO.  In the following
             sections of this report, MOMED Holding Co. and Missouri
             Medical Insurance Company "MOMEDICO" are referred to herein
             as the Company since the primary business activity is
             providing professional liability insurance to physicians
             through MOMEDICO.
 
             On February 2, 1996, the Company signed a letter of intent with
             MAIC Holdings, Inc. of Birmingham, Alabama, wherein MOMED
             Holding co. would enter into negotiations to become a wholly
             owned subsidiary of MAIC.  For additional information refer
             to Note 18 of notes to consolidated financial statements, 
             which are incorporated herein by reference.

             Missouri Medical Insurance Company "MOMEDICO" was organized
             by the Missouri State Medical Association (MSMA) in 1978 as
             the sponsored medical professional liability insurer for its
             members, and the Company estimates that it insured
             approximately 18% of the MSMA members as of December 31,
             1995.

    B.       Financial Information About Industry Segments.
             The Company is only involved in one segment of the insurance
             industry, that being medical professional liability
             insurance.  The financial information regarding the Company's
             operations is incorporated by reference in Part II, Item 8.

    C.       Narrative Description of Business.
             The primary business of the Company is selling and issuing
             policies of medical professional liability insurance to
             eligible physicians, dentists, professional partnerships and
             corporations whose members are physicians licensed to
             practice and are practicing in the State of Missouri and
             Kansas and to Certified Registered Nurse Anesthetists.  100%
             of the company's premium income is derived from medical
             professional liability insurance.

             During 1990, the Company discontinued selling office premises
             liability insurance (also known as owner's, landlord's and
             tenant's insurance) covering liability for bodily injury and
             property damage arising out of the use of the insured office
             premises.

             The Company provides twelve-month policies with optional
             installment payment plans available on a quarterly or
             semiannual basis.  Selection of an option by an insured
             increases the installment payments of the premium by a
             service charge based on a 9% annual rate.

             As of December 31, 1995, the Company insured 1,496
             physicians, dentists and corporations.

             Prior to June 30, 1986, the Company had written primarily the
             traditional form of medical professional liability insurance
             policy which is known as an "occurrence" policy.  Effective
             July 1, 1986, all new and renewal medical professional
             liability policies were issued on a policy form known as a
             "claims made" policy.  The primary difference between the two
             forms of policies is that the "occurrence" policy offers
             coverage for any covered claim arising from an occurrence
             during the policy period regardless of whether the claim is
             made during or after the end of the policy period.  Whereas,
             under a "claims made" policy, an insurer indemnifies the
             insured only against liability for claims which relate to an
             event occurring after the effective date of the policy and
             while it is in force and which are actually asserted against
             him during such period.  Thus under a "claims made" policy,
             once a policy period ends, the insured is no longer
             indemnified against liability for acts committed during that
             policy period and for which no claims have yet been asserted
             against him.  He is able to obtain indemnification for such
             acts only by continuing to  purchase additional insurance for
             subsequent policy periods during which any such claim may
             possibly be asserted.  The basic professional liability
             policy issued by the Company in the State of Missouri
             provides a limit of liability of $200,000 for loss resulting
             from any one claim or suit or all suits because of injury or
             death of any one person and an annual aggregate limit of
             $600,000 which is the total limit of the Company's liability
             during the effective policy period.  Such limits of liability
             apply separately to each insured.  Increased limits are also
             available in the amount of $500,000/$1,500,000;
             $1,000,000/$2,000,000; $2,000,000/$3,000,000; 
             $2,000,000/$4,000,000; $3,000,000/$5,000,000; and
             5,000,000/$7,000,000.

             The Company is authorized to write primary limits of
             $200,000/$600,000 in the State of Kansas.  The Kansas Health
             Care Stabilization Fund requires physicians to purchase
             excess coverage in one of the following amounts,
             $100,000/$300,000; $300,000/$900,000, and
             $800,000/$2,400,000.  The Company offers excess coverage over
             the amounts available from the Fund up to a maximum of
             $5,000,000/$7,000,000.
             
             The Company is subject to ongoing regulations by the Director
             of the Department of Insurance of Missouri.  Such regulation
             includes, among other things, review of premium rates and
             policy forms, adequacy of reserves, adequacy of capital and
             surplus, and other matters pertaining to insurance and the
             operation of the Company.  During 1993, the Department of
             Insurance performed an examination of the statutory
             statements for the two years ended December 31, 1992.  There
             were no changes to the Company's statutory financial
             statements for this period.

             The medical professional liability insurance market is a
             highly competitive segment of the total insurance industry. 
             The Company estimates that it has written approximately 15%
             of the physicians medical professional liability insurance
             presently in effect in the State of Missouri.  Based on
             Company estimates and published information, the Company
             believes that the balance was written by Medical Protective
             Company (20%), St. Paul Fire and Marine Insurance Company
             (5%), PIE Mutual Insurance Company of Ohio (20%), Intermed
             Insurance Company (12%), Medical Defense Associates, Ltd.
             (15%), and 13% by others.  The first two companies are larger
             and better capitalized and have been in business longer than
             the Company.  Other non-Missouri domiciled companies have
             adopted very aggressive pricing structures to gain market
             share.

             At December 31, 1995, the Company had 20 full time employees.

    D.       Financial Information about Foreign and Domestic Operations
             and Export Sales
             The Company has no foreign operations and is licensed to sell
             casualty insurance other than auto in the States of Missouri
             and Kansas.

Item 2. Description of Property

             The Company acquired a building in St. Louis, Missouri on
             June 1, 1992, and utilizes approximately one-half of the
             space for its home office and the remainder is leased to
             other companies.  The Company acquired permanent financing in
             the amount of $600,000 with interest at 7.75%.  The financing
             is for a period of four years and matures on October 31,
             1997.  As of December 31, 1995 the Company owed $513,333 on
             this loan.

             The Company acquired two parcels of real estate in Jefferson
             City, Missouri on September 19, 1989, at a cost of $121,687. 
             Renovation of the structures were completed during 1992 at a
             cost of $168,732, and MOMEDICO moved its Central Missouri
             Claims office into one of the buildings.  On June 30, 1995,
             the Company sold the parcel of real estate adjacent to its
             Central Missouri claims office and net proceeds from the sale
             of approximately $54,000 were applied to the mortgage.  The
             Company reported a gain of $1,962 on the sale.  At December
             31, 1995, the Company owed $180,310 on a bank loan with
             interest at 8.00%.  The loan matures on September 1, 1996. 
             The Company expects to refinance both loans at their maturity
             and does not anticipate difficulties in the refinancing
             activities.

Item 3. Legal Proceedings

             The Company has no lawsuits or outstanding settlements other
             than those related to claims arising out of the normal
             operations of the Company's primary business, which are
             covered by the reserves for losses and loss adjustment
             expenses.

Item 4. Submission of Matters to a Vote of Security Holders

    A.       Special Meeting of Shareholders, December 8, 1995.

    C.       To approve or disapprove a proposal to increase the number of
             authorized shares of Class A Common Stock $1.00 par value, to
             One Million (1,000,000) shares to accommodate a three-for-one
             stock split:

             Votes:  For   184,726     Against    0         Abstain    0 


                                                                Part II

Item 5. Market for the Registrant's Common Equity and Related
Stockholder Matters.

    A.       At the time of this report, there is a limited number of
             marketmakers for the registrant's Class A Common Stock. The
             bid and ask price during 1995, adjusted for the three for one
             stock split, ranged from $2.50 bid; $2.67 ask to $2.50 bid;
             $0 ask at December 31, 1995.  The bid and ask price during
             1994 ranged from $2.00 bid; $2.67 ask to $2.50 bid; $2.67 ask
             at December 31, 1994.  The bid and ask price during 1993
             ranged from $2.00 bid; $2.50 ask to $1.83 bid, $2.33 ask at
             December 31, 1993.  
 
             The 24,185 Class B common stock held by Missouri State
             Medical Association (MSMA) was exchanged on a share-for-share
             basis into 24,185 Class A Common stock of the Company on
             August 16, 1994.  In conjunction with this exchange, the
             Company authorized and issued 24,185 Class C non-voting
             common stock at $1.00 par value to MSMA.  MSMA has an option
             to sell the Class C shares and the Company is required to
             purchase such shares at a per share consideration of $24.81,
             with the aggregate cash consideration not to exceed $600,000.

             On February 24, 1995, the Board of Directors adopted a
             Shareholder's Protection Rights Plan.  This plan is designed
             to protect the shareholders from persons attempting to
             acquire shares by a partial tender offer, or by buying shares
             in the market or in negotiated transactions, without paying
             a fair premium for control and without offering a fair price
             to all stockholders.  For additional information refer to
             Note 17 of notes to consolidated financial statements, which
             are incorporated herein by reference.

             On September 8, 1995, the Board of Directors declared a
             three-for-one split of the Company's Class A common stock. 
             The additional 493,056 shares arising from the split were
             distributed on January 22, 1996, to shareholders of record as
             of November 8, 1995.
             
     B.      The approximate number of stockholders of record as of March
             1, 1996, of Class A stock was 272.   


     C.      The Company paid no dividends during 1995.  The registrant
             declared a dividend of $.25 per share on Class A and Class B
             common stock on May 10, 1991, to shareholders of record on
             May 15, 1991, payable May 29, 1991.  This was the first
             dividend paid by the registrant and was not to be considered
             as a commitment to pay regular annual dividends, nor should
             it be viewed as an amount which might be used for any future
             dividends.  The registrants ability to pay dividends in the
             future is restricted to the extent of its primary subsidiary
             MOMEDICO being able to pay dividends to the registrant. 
             MOMEDICO's ability to pay dividends is restricted to the
             extent of maintaining adequate statutory capital and surplus. 
             Information contained in Note 12 of notes to consolidated
             financial statements on page  27 of the registrant's 1995
             annual report to stockholders explains such restrictions, a
             copy of which is filed as Exhibit  13 hereto, is hereby
             incorporated by reference.

Item 6.  Selected Financial Data

             See Item 8

Item 7.  Management's Discussion and Analysis of Financial
Condition and Results of Operation
    
             See Item 8

Item 8.  Consolidated Financial Statements and Supplementary Data

             The information required by Items 6, 7, and 8 of this Part II
             are hereby incorporated by reference to pages 13 through 28
             of the registrants' 1995 annual report to stockholders, a
             copy of which is filed as Exhibit 13 hereto.

Item 9.  Changes in and disagreements with Accountants on
Accounting and Financial Disclosures

             None

                                                               Part III
Item 10. Directors and Executive Officers of the Registrant
    (a) Identification of Directors

                                                  Period of
                                                  Service
                                   Position       as a
                                    with          Director        Principal
       Name                   Age  Company        of company      Occupation 

Richard V. Bradley, M.D. (1)   69  President &      
                                   Chief Exec.                       
                                   Officer & 
                                   Director   1978 to date   General Surgeon

Norman P.Knowlton,III, MD(2)  47   Director   1990 to date   Internal 
                                                             Medicine

Thomas J. Cooper, M.D. (3)    71   Director   1981 to date   Pathologist

Leonard L. Davis, M.D. (4)    72   Director   1987 to date   Orthopaedic
                                                             Surgeon

H. Peter Ekern, M.D. (5)      62   Director   1986 to date   Family Practice
                                                             Physician

Eugene T. Hansbrough, M.D.(6) 70   Director   1978 to date   General Surgeon

R.J. King (7)                 82   Director   1986 to date   Retired Ins.
                                                             Agency Owner

Howard E. Linville, M.D. (8)  72   Chairman   1978 to date   Retired General
                                                             Surgeon

John I. Matthews, M.D. (9)    76   Director   1981 to date   Internist


Dale E. Darnell, M.D. (10)    61   Director  1988 to date    Orothopaedic
                                                             Surgeon

Garth S. Russell, M.D. (11)   66   Chief
                                   Financial                  
                                   Officer                    Orthopaedic
                                   & Director 1978 to date    Surgeon

James M. Stokes, M.D. (12)    71   Secretary
                                   Treasurer
                                   Chief Acctg
                                   Officer & 
                                   Director   1978 to date    General Surgeon

Robert T. Gibbons, Jr. MD(13) 52   Director   1991 to date    Anesthesiologist


Meredith J. Payne, M.D. (14)  69   Director   1991 to date    Plastic and 
                                                             General Surgeon

Gary A. Dyer, M.D. (15)       56   Director   1993 to date    Dermatologist


        (b) Identification of Executive Officers
                                                     Period of
                                                     Service as
                                  Position with      an Officer    Principal  
      Name                Age     Company            of company    Occupation 
                            
Richard V. Bradley, MD (1)  69   President & Chief 
                                 Executive Officer  1978 to date  General
                                                                  Surgeon

James M. Stokes, MD (12)    71   Secretary-Treasurer
                                 Chief Accounting
                                 Officer & Director 1978 to date  General
                                                                  Surgeon

Garth S. Russell, MD (11)   66   Chief Financial                  Orthopaedic
                                 Officer and                      Surgeon
                                 Director           1978 to date


Kriete Hollrah (16)         56  Executive Vice                    Executive
                                President                         Vice
                                                   1990 to date   President

Russell L. Oldham (17)      61  Vice President    1989 tp date    Vice 
                                Claims & Field                    President
                                                                  Claims & 
                                                                  Field
                                                                  Services
                                               

Patricia J. Walsh (18)      36 Assistant Vice    1992 to date     Assistant
                               President                          Vice Pres.
                               Underwriting                       Undewriting

Kimberly A. Wolterman (19)  40 Vice President    1995 to date     Vice
                               Marketing &                        President
                               Risk Management                    Marketing &
                                                                  Risk 
                                                                  Management 
  

      (c) Identification of Certain Significant Employees
              The registrant has no significant employees who are not executive
      employees.

      (d) Family Relationships
              None

      (e) Business Experience
              See Notes 1-19.

    1.  Dr. Bradley was engaged in the practice of medicine in St. Louis
        County, Missouri as a general surgeon for more than five years prior
        to 1986.  Effective October 1, 1986, he began his retirement from
        medical practice to devote his full time to serve as President and
        Chief Executive Officer of Momed Holding Co. and MOMEDICO.  He was
        Vice President of MOMEDICO from 1978 to 1980.  On December 3, 1980, he
        was elected President and Chief Executive Officer.  He serves on the
        Board of Directors of the Physicians Insurers Association of America
       (PIAA), and Blue Choice HMO Missouri and he is a past President of the
       Missouri State Medical Association (MSMA).
 
  2.  Dr. Knowlton, III has been in the private practice of medicine
      for more than the past five years specializing in the area of internal
      medicine.  Dr. Knowlton is associated with The Springfield Clinic of
      Internal Medicine, Springfield, Missouri.  He serves on the Board of
      Directors of MOMEDICO and is Secretary of the Missouri State Medical
      Association (MSMA).

  3.  Dr. Cooper is a pathologist and former owner of Pathology
      Associates, now retired.  He serves on the Board of Directors of
      MOMEDICO and is a past President of the St. Louis Metropolitan Medical
      Society and a past President of MSMA.

  4.  Dr. Davis is an orthopaedic surgeon.  Since 1991 he has been
      employed by the University of Missouri Health Sciences Center,
      Columbia, Missouri.  From July 1985 he had been employed by
      Healthline, a division of St. Louis University, where his work related
      primarily to industrial medicine and disability evaluation.  He serves
      on the Board of Directors of MOMEDICO and is a member of MSMA, AAOS,
      and the Missouri Orthopedic Society.

  5.  Dr. Ekern has been engaged in the practice of medicine as a
      family practice physician for more than the past five years.  He is
      president of H. Peter Ekern, Inc., a director of Commerce Bank, N.A.,
      Mexico, Missouri, a director of MOMEDICO, and a director of MSMI a
      wholly-owned subsidiary of MSMA.  He is a past president of MSMA.

  6.  Dr. Hansbrough, prior to retirement had been in the private
      practice of medicine as a general surgeon practicing with Kneibert
      Clinic, Poplar Bluff, Missouri for more than the past five years.  He
      is a Director of Commerce Bank of Poplar Bluff, 686 Real Estate
      Partnership, serves on the Board of Directors of MOMEDICO and is a
      past President of MSMA.

  7.  R.J. King, who retired in 1979, was previously a general insurance
      agent and owner of King Insurance Agency for more than five years.  He
      now serves as a Director of MOMEDICO and is a former member of the
      Missouri House of Representatives.

 8.  Dr. Linville prior to retirement, had been in the private
     practice of medicine as a general surgeon practicing in Kansas City,
     Missouri for more than the past five years.  He has served as Chairman
     of the Board of MOMED Holding Co. and MOMEDICO since December 10,
     1993.  He is a member of the Executive Committee.

 9.  Dr. Matthews prior to retirement, had been in private practice of
     medicine as an internist in Jefferson City, Missouri for more than the
     past five years.  He serves on the Board of Directors of MOMEDICO and
     is a the past President of MSMA, and past Chairman of MSMA Legislative
     Committee.

10.  Dr. Darnell has been engaged in the private practice of
     orthopaedic surgery as an associate with Dickson-Diveley Midwest
     Orthopaedic Clinic, Incorporated in Kansas City, Missouri for more
     than the past five years.  He serves on the Board of Directors of
     MOMEDICO and is the past President of the Kansas City Orthopaedic
     Society, past-chairman of the Department of Orthopaedic Surgery at St.
     Lukes Hospital, is an Associate Professor of surgery with the Division
     of Orthopaedic Surgery at the University of Missouri-Kansas City
     School of Medicine and a member of the American Academy of Orthopaedic
     Surgeons.

11.  Dr. Russell has been in the private practice of medicine as an
     orthopaedic surgeon for more than the past five years.  He is the
     Chief Financial Officer of Momed Holding Co. and MOMEDICO and serves
     on the Board of Directors of MOMEDICO.  He is President of Great
     Rivers Holding Co. an insurance holding company and is a past
     President of the Orthopaedic Society.

12.  Dr. Stokes prior to retirement, had been in the private practice
     of medicine as a surgeon in  St. Louis County, Missouri for more than
     the past five years.  He is chairman of the Audit Committee,
     Secretary, Treasurer and Chief Accounting Officer of Momed Holding Co.
     and MOMEDICO and serves on the Board of Directors of MOMEDICO.  He is
     a past President of the St. Louis Metropolitan Medical Society and a
     past President of MSMA.

13.  Dr. Gibbons has been in the private practice of medicine as an
     anesthesiologist for more than the past five years.  He serves on the
     Board of Directors of MOMEDICO and is Medical Director of Surgicenter
     of Johnson County, Councilor, District VII of MSMA and an AMA
     Delegate.

14.  Dr. Payne has been in the private practice of medicine as a
     plastic and general surgeon for more than the past five years.   She
     serves on the Board of Directors of MOMEDICO and is assistant
     professor, Department of Plastic Surgery, St. Louis University School
     of Medicine, Chief of Department of 
     Plastic Surgery, John Cochran Veteran's Hospital, a member of the
     Board of Directors of NewCo Enterprises, Inc., St. Charles, MO, and a
     Councilor of MSMA.
               
15.  Dr. Dyer has been in the private practice of dermatology in St.
     Joseph, Missouri for more than the past five years.  He serves on the
     Board of Directors of MOMEDICO and is a past president of MSMA,
     Missouri Dermatological Society, Missouri University Medical School
     Foundation, Kansas City Dermatological Society, and Buchanan County
     Medical Society.  Vice Chairman and Associate Counselor, Missouri
     Dermatology Section, Southern Medical Association, past Missouri State
     Chairman, Leaders Society Campaign, Dermatology Foundation.

16.  Mr. Hollrah joined the Company in September 1990, as Vice
     President of Finance and Administration.  He was promoted to the
     position of Executive Vice President in September, 1992.  Prior to
     September 1990, Mr. Hollrah was a principal and stockholder of the
     firm of Mortland & Co., P.C., Certified Public Accountants since
     February 1977.

17.  Mr. Oldham was promoted to Vice President of Claims/Field
     Services with MOMEDICO in October 1989 and prior to that was Assistant
     to the President since April, 1988.  Prior to April 1988, Mr. Oldham
     was employed by AVEMCO Aviation Insurance Company, as Vice President
     of Claims since December, 1980.

18.  Ms. Walsh was promoted to Assistant Vice President of
     Underwriting with MOMEDICO on January 15, 1992 and prior to that was
     Senior Underwriter since 1988 and was the underwriter since April 22,
     1985.

19. Mrs. Wolterman was promoted to Vice President of Marketing and
    Risk Management on February 1, 1996, prior to that she was Assistant
    Vice President of Marketing from July 26, 1995 and prior to that she
    was Marketing Director from August 1, 1985.  She has been employed by
    the Company since July 26, 1982.

    (f) Involvement in Certain Legal Proceedings
       None of the Directors or Officers identified in paragraphs (a) and (b)
       of this Item have been involved in any legal proceedings required to
              be disclosed herein. 

Item 11.  Executive Compensation

      (a) General
The registrant qualifies as a "small business issuer,"  as defined by item
10(a)(1) of Regulation S-B.

          (b) Summary Compensation Table

                                     Summary Compensation Table
                                               Long-Term Compensation
              Annual Compensation Awards                     Payouts



                                                                          

Name and                             Other   Restricted                 All
Principal                            Annual     Stock   Options/  LTIP   other
Position  Year   Salary    Bonus     Compens.   Awards    SARs   Payouts Comp.

Richard V.
 Bradley, M.D.

President &
 Chief Executive
 Officer 
    1995       $208,573    0           0           0       0        0          0
    1994       $202,479    0           0           0       0        0          0
    1993       $196,511    0           0           0       0        0          0
Kriete
 Hollrah

Executive Vice 
 President
    1995       $121,638    0           0           0       0         0         0
    1994       $111,175    0           0           0       0         0         0


                
(c) Option/SAR Grants Table
(1) The Registrant has no option/SAR programs for executive officers.

(d) Aggregate Option/SAR Exercises and Fiscal Year-End Option/SAR Value Table
                  None

(e) Long-Term Incentive Plan ("LTIP") Awards Table
                  None


(g) Compensation of Directors
Directors receive an annual retainer of $1,000 per year plus a fee of  $500
per meeting, plus reimbursement of expenses incurred in attending meetings
concerning Company business.  There are no other forms of director
compensation.


(h) Employment Contracts and Termination of Employment and Changes in Control
Arrangements
The Registrant has entered into a contract with Bradley DeMonbrun, Ltd. for
the services of its President and Chief Executive Officer.  The rate of
compensation is reviewed and approved annually by the Board of Directors.

In the event the Registrant is acquired by purchase of its assets or
controlling shares and the services of the President and Chief Executive
Officer are not retained, Bradley DeMonbrun, Ltd. shall receive monthly
compensation for the term of the agreement then in effect.

(i) Report on Repricing of Options/SAR's

The Registrant has no options or SAR programs for executive officers.


Item 12.  Security Ownership of Certain Beneficial Owners and Management

       (a) Security Ownership of Certain Beneficial Owners as of December
           31, 1995.

    (1)                                  (2)         (3)              (4)
                        Name and Address         Amt & Nature      
Title of             of Beneficial           of Beneficial        Percent
  Class                   Owner                  Owner(4)          of Class

Class A Common (3)

                    Missouri State Medical Assoc.  72,555 (1)       9.8%
                    Jefferson City, MO
                 
                    Richard V. Bradley, M.D.       40,956           5.5%
                    St. Louis, MO

                    Leonard L. Davis, M.D.         39,186           5.3%
                    Mexico, MO 

                    Thomas J. Cooper, M.D.         37,593           5.1%
                    St. Louis, MO 

                    Garth S. Russell, M.D.         47,733           6.5%
                    Columbia, MO

                    CEDE & Company                 52,077           7.0%
                    New York, NY

                    Missouri Medical Ins. Co.      60,144 (2)       8.1%
                    St. Louis, MO

(1)        Missouri State Medical Association exchanged 100% of the Class B
           common stock on August 16, 1994 for Class A common stock, and MSMI,
           a wholly owned subsidiary, owns 12,000 Class A common shares.

(2)        The registrant holds these shares as treasury shares.

(3)        The registrant knows of no other persons or groups that have
           beneficial ownership of more than 5% of the Class A common stock as
           of December 31, 1995.
          
(4)        Adjusted for three-for-one stock split payable to holders of record
           on November 8, 1995.





          (b)Security Ownership of Management.

     Title of                 Amount of Nature of
      Class                  Beneficial Ownership           Percent of Class

Class A Common:
     (Name)

Richard V. Bradley, M.D.       40,956                                 5.54%

Thomas J. Cooper, M.D.         37,593                                 5.08%

Dale E. Darnell, M.D.           3,600                                  .49%

Leonard L. Davis, Jr., M.D.    39,186                                 5.30%

Gary A. Dyer, M.D.              3,000                                  .41%

H. Peter Ekern, M.D.              450                                   *

Robert T. Gibbons, Jr., M.D.      300                                   *

Eugene T. Hansbrough, M.D.      6,000                                  .81%

Kriete Hollrah                 11,562                                 1.56%

R.J. King                       6,750                                  .91%

Norman P. Knowlton, III, M.D.     300                                   *

Howard E. Linville, M.D.        3,000                                  .41%

John I. Matthews, M.D.         19,719                                 2.67%

Russell L. Oldham               3,420                                  .46%

Meredith J. Payne, M.D.           300                                   *

Garth S. Russell, M.D.         47,733                                 6.45%

James M. Stokes, M.D.             600                                   *   

Patricia J. Walsh                 150                                   *

Kimberly A. Wolterman             525                                   *  

All directors and officers
  as a group (19 persons)     225,144                                30.44%

*Less than 1/10th of 1%.

      (c)Changes in Control.

              None
Item 13.  Certain Relationships and Related Transactions.

              None

                                                         PART IV


Item 14. Exhibits, Financial Statement Schedules and Reports on Form 8-K

      (a)  The following documents are filed as a part of this report.

  1.       Financial Statements:
           Consolidated Balance Sheets, December 31, 1995 and 1994
           Consolidated Statements of Operations, for the years ended
              December 31, 1995, 1994, and 1993.
           Consolidated Statements of Stockholders' Equity, for the years
             ended December 31, 1995, 1994 and 1993.
           Consolidated Statements of Cash Flows, for the years ended
             December 31, 1995, 1994, and 1993.
           Notes to Consolidated Financial Statements.
           

          Independent Auditors' Report
             (All incorporated herein by reference to pages 18 through 28 of
      the 1995 annual report to stockholders.)

 2.       Financial Statement Schedules:
          Schedule II - Condensed Financial Information of Registrant.
          Schedule III - Supplementary Insurance Information
          Schedule IV - Reinsurance
          Schedule VI - Supplemental Information Concerning
                        Property-Casualty Insurance Operations
         (All other schedules are omitted because they are not applicable
           or not required, or because the required information is included
           in the consolidated financial statements or notes thereto).

 3.       Exhibits - Securities Exchange Act of 1934 - 10-K:

          (3)     Articles of Incorporation and By-Laws
          (13)    1995 Annual Report to Stockholders
          (21)    Subsidiaries of the Registrant
          (24)    Power of Attorney
          (27)    Financial Data Schedule
          (28)    Information from reports furnished to state insurance
                    regulatory authorities.

      (b)     Reports on Form 8-K

        There were no reports required to be filed on Form 8-K during the
        fourth quarter of 1995.


                                   SIGNATURES

      Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.


                                                       MOMED HOLDING CO.        
                                                       (Registrant)


                                           BY    Richard V. Bradely, M.D.      
                                                 Richard V. Bradley, M.D.
                                                 President


Date:  March 29, 1996



                                              INDEPENDENT AUDITORS' REPORT




The Board of Directors and Stockholders
MOMED Holding Co.

Under date of March 8, 1996, we reported on the consolidated balance sheets
of MOMED Holding Co. and subsidiaries as of December 31, 1995 and 1994, and
the related consolidated statements of operations, stockholders' equity, and
cash flows for each of the years in the three-year period ended December 31,
1995, as contained in the 1995 annual report to stockholders.  These
consolidated financial statements and our report thereon are incorporated by
reference in the annual report on Form 10-K for the year 1995.  In connection
with our audits of the aforementioned consolidated financial statements, we
also have audited the related financial statement schedules listed in Item
14.  These financial statement schedules are the responsibility of the
company's management.  Our responsibility is to express an opinion on these
financial statement schedules based on our audits.

In our opinion, such financial statement schedules, when considered in
relation to the basic consolidated financial statements taken as a whole,
present fairly, in all material respects, the information set forth therein.

As discussed in note 2 of the consolidated financial statements, the Company
adopted the provisions of Financial Accounting Standards Board's Statement of
Financial Accounting Standards No. 115 "Accounting for Certain Investments in
Debt and Equity Securities" in 1994.  Also, as discussed in note 2 to the
consolidated financial statements, the Company adopted the provisions of
Financial Accounting Standards Board's Statement of Financial Accounting
Standards No. 109 "Accounting for Income Taxes" in 1993.



                                KPMG Peat Marwick LLP
St. Louis, Missouri
March 8, 1996


                                                                SCHEDULE II

                                           MOMED HOLDING CO.
                               Condensed Financial Information of Registrant
                                      Condensed Balance Sheets
                                     December 31, 1995 and 1994

                                                      1995            1994  
ASSETS
<TABLE>
<S>                                               <C>              <C>          
Assets                                           $    33,491         207,924   

 Short-term investments                              277,430           ---   
 Investment real estate net of depreciation
   of $36,480 in 1995 and $36,616 in 1994            156,392         216,303 
 Investment in subsidiaries, at equity            16,813,898       9,807,940  
 Land, building, and equipment, at cost
  less accumulated depreciation 
  of $95,890 in 1995 and $66,634 in 1994             785,406         799,019 
 Other assets                                        431,563         292,809 
     Total assets                                $18,498,180      11,323,995  


LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities:

     Accounts payable                                 12,129           8,579  
     Mortgages payable                               693,643         799,640  
     Other liabilities                               177,523          77,100   
 
          Total liabilities                          883,295         885,319   
 
Class C Non-voting Common Stock $1.00 par 
   value, redeemable,
   authorized and issued 24,185                      600,000         600,000   


Stockholders' equity:

  Class A Common Stock, $1 par value                 739,584         246,528 
  Additional paid in capital                         852,504       1,345,560    
  Unrealized appreciation (depreciation) 
   of fixed maturity investments and 
   equity securities of subsidiary, 
   net of tax                                      1,818,080      (1,281,104)  
 
Retained earnings                                 13,655,007       9,577,982  
     
                                                  17,065,175       9,888,966 
Class A treasury shares at cost, 67,530
  shares in 1995 and 22,510 shares in 1994           (50,290)        (50,290)  

Total stockholders' equity                        17,014,885        9,838,676  
Total liabilities & stockholders equity          $18,498,180       11,323,995
</TABLE>

     See Notes to Consolidated Financial Statements.


                                                                SCHEDULE II
                                             MOMED HOLDING CO.
                               Condensed Financial Information of Registrant
                                     Condensed Statements of Operations
                                        Years Ended December 31, 





                                               1995        1994      1993   
      
<TABLE>
<S>                                       <C>          <C>          <C>
Revenues                                  $2,624,571   2,558,040    2,593,816 
General and administrative expenses        2,398,651   2,366,422    2,373,977  
Earnings before income tax (expense)
 and equity in net earnings
  (loss) of subsidiaries                     225,920     191,618      219,839 
Income tax (expense) benefit                 (86,052)    (54,980)      62,092   
Earnings before equity in net earnings
 (loss) of subsidiaries                      139,868     136,638      281,931 
Equity in net earnings (loss) of 
  subsidiaries, net of taxes               3,937,157   1,576,501     (700,470)  

Net earnings (loss)                       $4,077,025   1,713,139     (418,539)  


</TABLE>

See Notes to Consolidated Financial Statements.



                                                                SCHEDULE II

                                  MOMED HOLDING CO.
                    Condensed Financial Information of Registrant
                         Condensed Statements of Cash Flows
                             Years Ended December 31, 


                                             1995         1994         1993   
<TABLE>
<S>                                     <C>             <C>         <C>  
Cash flows from operating activities:   
      Net earnings (loss)               $4,077,025      1,713,139   (418,539)
      Adjustments to reconcile net 
       earnings to cash provided by 
       operating activities:
      Equity in net (earnings) loss of 
       subsidiaries                     (3,937,157)    (1,576,501)   700,470  
      Other, net                            85,446        (22,208)  (141,022)  

      Net cash provided by operating
        activities                         225,314        114,430    140,909 
Cash flows from investing activities:
      Investment real estate purchased      ---            (7,530)     ---     
      Purchase of land, building, 
       and equipment                       (16,320)       (25,252)   (33,290)  
      Net cash used by investing 
       activities                          (16,320)       (32,782)   (33,290)   


Cash flows from financing activities:
      Repayment of mortgage loans         (105,997)       (50,387)   (56,560)
      Stock exchange expenses               ---           (36,013)      ---    
      
      Net cash provided (used) by
       financing activities               (105,997)       (86,400)   (56,560)  

      Net increase(decrease) in cash       102,997         (4,752)    51,059 

      Cash and short term investments 
        at beginning of year               207,924        212,676    161,617    
      Cash and short-term investments  
        at end of year                   $ 310,921        207,924    212,676    
</TABLE>


See Notes to Consolidated Financial Statements.  


                                                     SCHEDULE III
                               MOMED HOLDING CO. AND SUBSIDIARIES

                               Supplementary Insurance Information

Col A       Col B               Col C          Col D       Col E     Col F

                               Future
                               Policy                       Other
           Deferred            Benefits                     Policy
           Policy              Losses                       Claims &
           Acquisition         Claims &      Unearned       Benefits  Premium
Segment    Cost                Loss Exp.     Premiums       Payable   Revenue


Year ended
 12/31/93
 Medical 
 Malpract. 159,078            59,569,371      5,946,430      -0-   10,645,733   

Year ended
 12/31/94
 Medical 
 Malpract. 146,503            58,764,316      6,343,858      -0-   10,539,879   

Year ended
 12/31/95
 Medical 
 Malpract. 154,955            54,903,753      6,553,559      -0-   11,666,363   



           Col G             Col H          Col I       Col J      Col K


                           Benefits        Amortization               
                           Claims          of Deferred
           Net             Losses &           Policy      Other
         Investment        Settelment      Acqusition     Operating  Premiums   
         Income            Expenses          Cost         Expenses    Written





Year ended
 12/31/93
 Medical 
 Malpract.  3,641,198      14,438,684       663,284     1,871,435  11,758,362   

Year ended
 12/31/94
 Medical 
 Malpract.  3,952,945       9,978,065       655,469     1,914,680  10,942,885   

Year ended
 12/31/95
 Medical 
 Malpract.  4,236,391      10,733,726       676,659     1,879,450  11,935,666 

See accompanying independent auditors' report.

                                                    SCHEDULE IV

                               MOMED HOLDING CO. AND SUBSIDIARIES
                                       REINSURANCE

   Column A         Column B   Column C    Column D    Column E    Column F   
                                Ceded to   Assumed                 Percentage
                      Gross      Other     From Other   Net        of Amount
                       Amt    Companies    Companies   Amount   Assumed to Net


Year ended December 
  31, 1993:
 Life Ins. Inforce    -0-       -0-             -0-       -0-          -0-

PREMIUMS

  Life Insurance      -0-       -0-             -0-       -0-          -0-
  Accident & 
    Health Ins.       -0-       -0-             -0-       -0-          -0-
  Property & Liab
      Ins.        12,489,962   731,600           -0-    11,758,362     -0-
  Title Ins.         -0-        -0-              -0-      -0-          -0-     

  Total Premiums  12,489,962   731,600           -0-    11,758,362     -0-  

Year ended December
  31, 1994:
 Life Ins. Inforce  -0-         -0-              -0-      -0-          -0-

PREMIUMS

  Life Insurance    -0-         -0-              -0-      -0-           -0-
  Accident & 
    Health Ins.     -0-         -0-              -0-      -0-           -0-
  Property & Liab
      Ins.      13,032,021    2,089,136          -0-   10,942,885       -0-
 Title Ins.         -0-         -0-              -0-      -0-           -0-   

 Total Premiums 13,032,021    2,089,136          -0-   10,942,885       -0-  


Year ended December
   31, 1995:
 Life Ins. Inforce -0-           -0-             -0-        -0-          -0-

PREMIUMS

  Life Insurance   -0-           -0-             -0-        -0-          -0-
  Accident & 
    Health In      -0-           -0-             -0-        -0-          -0-
  Property & Liab
      Ins.    12,598,948       663,282           -0-     11,935,666      -0-  
  Title Ins        -0-           -0-             -0-        -0-          -0-    

Total Premiums 12,598,948      663,282           -0-     11,935,666      -0-  

  See accompanying independent auditors' report.

                                                    SCHEDULE VI
                                MOMED HOLDING CO. AND SUBSIDIARIES
                                   Supplemental Information


Col A            Col B           Col C            Col D     Col E     Col F
<TABLE>
<S>          <C>          <C>               <C>         <C>       <C>

                                                Discount               
               Deferred       Reserve           if any
Affiliation     Policy         for Clms          Deduct   
with         Acquisition      Adjust.           in Col     Unearned   Earned
Registrant      Cost          Expense             C        Premium    Premium

Year ended
 12/31/93
 Medical 
 Malpract.    159,078      59,569,371        5,946,430      -0-    10,645,733   

Year ended
 12/31/94
 Medical 
 Malpract.    146,503      58,764,316        6,343,858      -0-    10,539,879 

Year ended
 12/31/95
 Medical 
 Malpract.   154,955       54,903,753        6,553,559      -0-    11,666,363  

</TABLE>

             Col G          Col H              Col I       Col J     Col K

                        Claims & Claim       Amrt.
                        Adjustment Exp.     of Def          Paid
              Net      Incurred Related      Pol            Claims
             Invest.         to             Acqst.          & Claim  Premiums
             Income     (1)     (2)          Cost           Adj Exp   Written
                       Cr Yr   Prior Yr                          

<TABLE>
<S>         <C>       <C>         <C>        <C>       <C>        <C>
Year ended
 12/31/93
 Medical 
 Malpract.  3,641,198 14,608,751  -170,067   663,284    8,375,901  11,758,362 

Year ended
 12/31/94
 Medical 
 Malpract.  3,952,945  11,384,334 -1,407,269 655,469    9,964,373  10,942,885

Year ended
 12/31/95
 Medical 
 Malpract.  4,236,391 15,186,892  -4,453,166 676,659   11,144,678  11,935,666
</TABLE>
See accompanying independent auditors' report.


                                                             EXHIBIT INDEX

    ( 3)             Article of Incorporation and By-Laws (20-49)

    (13)             1995 Annual Report to Stockholders (50-81)
  
    (21)             Subsidiary of the Registrant (82)

    (24)             Power of Attorney (83-84)

    (27)             Financial Data Schedule (85)

    (28)             Information from Reports Furnished to State Insurance
Regulatory Authorities (86-87)